Cargando…
Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
Autores principales: | Song, Chengli, Wang, Lina, Xu, Qiang, Wang, Kai, Xie, Dan, Yu, Zhe, Jiang, Kui, Liao, Lujian, Yates, John R., Lee, Jiing-Dwan, Yang, Qingkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445621/ https://www.ncbi.nlm.nih.gov/pubmed/28548101 http://dx.doi.org/10.1038/srep46833 |
Ejemplares similares
-
Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
por: Song, Chengli, et al.
Publicado: (2017) -
Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
por: Song, Chengli, et al.
Publicado: (2015) -
Corrigendum to ‘Induction of Wnt signaling antagonists and p21-activated kinase enhances cardiomyocyte proliferation during zebrafish heart regeneration’
por: Peng, Xiangwen, et al.
Publicado: (2022) -
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021) -
Corrigendum: Oxygen impairs oligodendroglial development via oxidative stress and reduced expression of HIF-1α
por: Brill, Christina, et al.
Publicado: (2017)